Skip to main content
Clinical Trials/NCT02678559
NCT02678559
Completed
Not Applicable

Preload Dependency Evaluation With Stroke Volume Variation During Alveolar Recruitment Manoeuvres

University Hospital, Clermont-Ferrand1 site in 1 country24 target enrollmentFebruary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
24
Locations
1
Primary Endpoint
Variation of stroke volume
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The principal aim is to assess impact of alveolar recruitment manoeuvres (ARM) on stroke volume variation, evaluated by trans-oesophageal echocardiography (TEE). These variations will be measured on preload dependency or preload independency status. The principal purpose is to determine if variations of stroke volume during standardized ARM can predict the preload dependency status.

Detailed Description

Population studied: anesthetized patients for cardiac surgery of coronary bypass. Secondary endpoints : - comparison between TEE and mini-invasive monitoring systems in accuracy of measurement of stroke volume variation during ARM. These mini-invasive systems are : Clearsight system (Edwards Lifescience) and Flotrac system (Edwards Lifescience) - Difference between pre and post-cardiopulmonary bypass status on principal purpose evaluation

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patient Undergoing a surgical procedure of coronary artery bypass, with cardiopulmonary bypass Written consent collected

Exclusion Criteria

  • Emergency case
  • Pericardial effusion
  • Aortic or mitral valvulopathy
  • Contraindication for : TEE, alveolar recruitment manoeuvre (emphysema, pneumothorax, hemodynamic instability), Ringer Lactate solution infusion
  • Bad echogenicity
  • Patient refusal to participate to the study
  • No health insurance

Outcomes

Primary Outcomes

Variation of stroke volume

Time Frame: at the beginning of cardiac surgery

Variation of stroke volume measured by TEE, induced by a standardized ARM, at the beginning of cardiac surgery

Secondary Outcomes

  • Pulse pressure variation (%) (Clearsight measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Perfusion index (pulsoxymeter)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Right ventricle diameter/left ventricle diameter ratio(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Cardiac index (l/min/m2)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • E/A ratio(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Sus-hepatic vein Doppler profile(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Heart rate (pulse/min)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Invasive arterial pressure (mmHg)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Stroke volume variation (%) (Clearsight measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Velocity time integral (cm)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Cardiac index (l/min/m2) (Clearsight measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Expired CO2 (mmHg)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Arterial pressure (mmHg) (Flotrac measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Central venous pressure (mmHg)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Stroke volume (ml) (Flotrac measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Stroke volume variation (%) (Flotrac measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Stroke volume (ml) (Clearsight measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Pulse pressure variation (%)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Cardiac index (l/min/m2) (Flotrac measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Near infrared spectroscopy : Cerebral SrO2(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Arterial pressure (mmHg) (Clearsight measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)
  • Pulse pressure variation (%) (Flotrac measurement)(After the cardiopulmonary bypass period, when sternotomy will be closed)

Study Sites (1)

Loading locations...

Similar Trials